Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Oncology Institute (TOI) Depreciation & Amortization (IS): 2021-2025

Historic Depreciation & Amortization (IS) for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to $1.7 million.

  • Oncology Institute's Depreciation & Amortization (IS) rose 953.59% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 1671.04%. This contributed to the annual value of $6.3 million for FY2024, which is 704.92% up from last year.
  • Latest data reveals that Oncology Institute reported Depreciation & Amortization (IS) of $1.7 million as of Q3 2025, which was up 953.59% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Depreciation & Amortization (IS) peaked at $1.8 million during Q2 2025, and registered a low of $777000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (IS) was $1.3 million (2023), whereas its average is $1.3 million.
  • Per our database at Business Quant, Oncology Institute's Depreciation & Amortization (IS) surged by 4973.54% in 2023 and then tumbled by 736.16% in 2024.
  • Oncology Institute's Depreciation & Amortization (IS) (Quarter) stood at $920000.0 in 2021, then grew by 29.57% to $1.2 million in 2022, then skyrocketed by 32.3% to $1.6 million in 2023, then increased by 8.24% to $1.7 million in 2024, then increased by 0.94% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.8 million for Q2 2025, and $1.8 million during Q1 2025.